Edoxaban may be effective treatment for atrial fibrillation after transcatheter aortic valve replacement

A new study compares edoxaban anticoagulant with the standard of care in large randomized clinical trial.

source https://www.sciencedaily.com/releases/2021/08/210829081922.htm